Your browser doesn't support javascript.
loading
Optimization of Advanced Molecular Genetic Testing Utilization in Hematopathology: A Goldilocks Approach to Bone Marrow Testing.
AlJabban, Ali; Paik, Henry; Aster, Jon C; Berliner, Nancy; Brouillard, Jennifer; Brown, Jennifer R; Burns, Kathleen H; Castillo, Jorge J; Card, James; Dal Cin, Paola; DeAngelo, Daniel J; Dorfman, David M; Ebert, Benjamin L; Garcia, Jacqueline S; Jacobson, Caron A; Lakhani, Hakim; Laubach, Jacob P; Ligon, Azra H; Lindeman, Neal I; Lindsley, R Coleman; Lovitch, Scott B; Luskin, Marlise R; Morgan, Elizabeth A; Nowak, Andrew; Petrides, Athena; Pinkus, Geraldine S; Pozdnyakova, Olga; Steensma, David P; Stone, Richard M; Weinberg, Olga K; Winer, Eric S; Kim, Annette S.
Affiliation
  • AlJabban A; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Paik H; Harvard Medical School, Boston, MA.
  • Aster JC; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Berliner N; Enterprise Research IS (ERIS), Digital, Mass General Brigham, Boston, MA.
  • Brouillard J; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Brown JR; Harvard Medical School, Boston, MA.
  • Burns KH; Harvard Medical School, Boston, MA.
  • Castillo JJ; Division of Hematology, Brigham and Women's Hospital, Boston, MA.
  • Card J; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Dal Cin P; Harvard Medical School, Boston, MA.
  • DeAngelo DJ; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Dorfman DM; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Ebert BL; Harvard Medical School, Boston, MA.
  • Garcia JS; Department of Pathology, Dana-Farber Cancer Institute, Boston, MA.
  • Jacobson CA; Harvard Medical School, Boston, MA.
  • Lakhani H; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Laubach JP; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA.
  • Ligon AH; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Lindeman NI; Harvard Medical School, Boston, MA.
  • Lindsley RC; Harvard Medical School, Boston, MA.
  • Lovitch SB; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Luskin MR; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
  • Morgan EA; Harvard Medical School, Boston, MA.
  • Nowak A; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Petrides A; Harvard Medical School, Boston, MA.
  • Pinkus GS; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Pozdnyakova O; Harvard Medical School, Boston, MA.
  • Steensma DP; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Stone RM; Department of Quality and Safety, Dana-Farber Cancer Institute, Boston, MA.
  • Weinberg OK; Harvard Medical School, Boston, MA.
  • Winer ES; Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA.
  • Kim AS; Department of Pathology, Brigham and Women's Hospital, Boston, MA.
JCO Oncol Pract ; 20(2): 220-227, 2024 Feb.
Article in En | MEDLINE | ID: mdl-37683132
Subject(s)
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Marrow / Hospitals Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: JCO Oncol Pract Year: 2024 Type: Article Affiliation country: Morocco
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Database: MEDLINE Main subject: Bone Marrow / Hospitals Type of study: Guideline / Prognostic_studies Limits: Female / Humans Language: En Journal: JCO Oncol Pract Year: 2024 Type: Article Affiliation country: Morocco